M&A Deal Summary

Kiadis Pharma BV Acquires Celmed BioSciences

On December 11, 2006, Kiadis Pharma BV acquired life science company Celmed BioSciences, Inc.

Acquisition Highlights
  • This is Kiadis Pharma BV’s 1st transaction in the Life Science sector.
  • This is Kiadis Pharma BV’s 1st transaction in Canada.

M&A Deal Summary

Date 2006-12-11
Target Celmed BioSciences, Inc.
Sector Life Science
Buyer(s) Kiadis Pharma BV
Deal Type Add-on Acquisition

Target

Celmed BioSciences, Inc.

Saint-Laurent, Canada
Celmed develops photodynamic-based therapies to treat hematological and immune diseases using its proprietary technology Theralux(TM).

Search 144,657 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial, then $150/Month

Buyer(S) 1

Buyer

Kiadis Pharma BV

Amsterdam, Netherlands

website


Category Company
SectorLife Science
DESCRIPTION

Kiadis Pharma is a clinical stage biopharmaceutical company pioneering a proprietary cell-based, personalized therapy for patients with blood cancers and related disorders, an area of significant unmet medical need.Kiadis Pharma’s unique and powerful platform technology has led to an initial experimental product, ATIR™, which has already been clinically tested on sixty patients.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Canada) 1 of 1
Year (2006) 1 of 1